hemotune is developping a revolutionary therapeutic blood purification platform.
hemotune has raised €4.7M across 1 funding round from 1 investor, most recently a Series A round in Aug 2020. Based in Zurich, Switzerland; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-08-12 | Series A | €4.7M |
| OCCIDENT |
| View deal → |
